- Datum02.04.2025
- UhrzeitLäuft gerade
- Veranstalter
XTB
Stefan Salomon
Moderator
Cytomx Therapeutics Inc. Aktie
Verkaufen
Kaufen
Cytomx Therapeutics Inc. Chart
Cytomx Therapeutics Inc. Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-9,81 %
Intraday
-2,37 %
1 Woche
-14,35 %
1 Monat
-43,69 %
Seit Jahresbeginn
-72,90 %
1 Jahr
-79,36 %
3 Jahre
-92,24 %
5 Jahre
Wikifolio
Passender Service zu Cytomx Therapeutics Inc.
Webinar zu Cytomx Therapeutics Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)0,560-5,850
- Jahrestief / Hoch ($)0,560-1,170
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Cytomx Therapeutics Inc.
Keine Dividenden verfügbar
Termine von Cytomx Therapeutics Inc.
Keine aktuellen Termine
Beschreibung
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
